Modeling and Monte Carlo simulations in oral drug absorption.

Drug dissolution, release and uptake are the principal components of oral drug absorption. All these processes take place in the complex milieu of the gastrointestinal tract and they are influenced by physiological (e.g. intestinal pH, transit time) and physicochemical factors (e.g. dose, particle size, solubility, permeability). Due to the enormous complexity issues involved, the models developed for drug dissolution and release attempt to capture their heterogeneous features. Hence, Monte Carlo simulations and population methods have been utilized since both dissolution and release processes are considered as time evolution of a population of drug molecules moving irreversibly from the solid state to the solution. Additionally, mathematical models have been proposed to determine the effect of the physicochemical properties, solubility/dose ratio and permeability on the extent of absorption for regulatory purposes, e.g. biopharmaceutics classification. The regulatory oriented approaches are based on the tube model of the intestinal lumen and apart from the drug's physicochemical properties, take into account the formulation parameters the dose and the particle size.

[1]  D. Farin,et al.  Use of fractal geometry to determine effects of surface morphology on drug dissolution. , 1992, Journal of pharmaceutical sciences.

[2]  Panos Macheras,et al.  The Mean Dissolution Time Depends on the Dose/Solubility Ratio , 2003, Pharmaceutical Research.

[3]  Panos Macheras,et al.  Fractal kinetics in drug release from finite fractal matrices , 2003 .

[4]  W. Schmitt,et al.  A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats , 2003, Pharmaceutical Research.

[5]  Raoul Kopelman,et al.  Fractal Reaction Kinetics , 1988, Science.

[6]  Panos Macheras,et al.  A Heterogeneous Tube Model of Intestinal Drug Absorption Based on Probabilistic Concepts , 1999, Pharmaceutical Research.

[7]  Bruce J. West,et al.  Fractal physiology , 1994, IEEE Engineering in Medicine and Biology Magazine.

[8]  F Langenbucher,et al.  Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution , 1972, The Journal of pharmacy and pharmacology.

[9]  Panos Macheras,et al.  Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples , 2004, Pharmaceutical Research.

[10]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[11]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[12]  Juergen Siepmann,et al.  A New Mathematical Model Quantifying Drug Release from Bioerodible Microparticles Using Monte Carlo Simulations , 2002, Pharmaceutical Research.

[13]  N. Peppas,et al.  A SIMPLE EQUATION FOR SOLUTE RELEASE PART 1. FICKIAN AND NONFICKIAN RELEASE FROM NONSWELLABLE DEVICES IN THE FORM OF SLABS, SPHERES, CYLINDERS OR DISKS , 1987 .

[14]  Panos Macheras,et al.  Gastrointestinal Drug Absorption: Is It Time to Consider Heterogeneity as Well as Homogeneity? , 1997, Pharmaceutical Research.

[15]  Panos Macheras,et al.  On the Heterogeneity of Drug Dissolution and Release , 2000, Pharmaceutical Research.

[16]  P. Lánský,et al.  Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity. , 2003, Journal of pharmaceutical sciences.

[17]  Panos Macheras,et al.  A Reappraisal of Drug Release Laws Using Monte Carlo Simulations: The Prevalence of the Weibull Function , 2003, Pharmaceutical Research.

[18]  Lawrence X. Yu,et al.  Compartmental transit and dispersion model analysis of small intestinal transit flow in humans , 1996 .

[19]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[20]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[21]  Panos Macheras,et al.  Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio , 2003, Pharmaceutical Research.

[22]  Gordon L. Amidon,et al.  Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.

[23]  Michael Levin Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .

[24]  Hans Leuenberger,et al.  Matrix type controlled release systems II. Percolation effects in non-swellable matrices , 1993 .

[25]  Petr Lánský,et al.  Modeling Heterogeneity of Particles and Random Effects in Drug Dissolution , 2001, Pharmaceutical Research.

[26]  G. Grass,et al.  Simulation models to predict oral drug absorption from in vitro data , 1997 .

[27]  Michael Weiss,et al.  Does the Dose-Solubility Ratio Affect the Mean Dissolution Time of Drugs? , 2004, Pharmaceutical Research.

[28]  J. Bonny,et al.  Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics. , 1991, Pharmaceutica acta Helvetiae.

[29]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[30]  K. Binder,et al.  A Guide to Monte Carlo Simulations in Statistical Physics: Preface , 2005 .

[31]  Panos Macheras,et al.  Heterogeneous Tube Model for the Study of Small Intestinal Transit Flow , 2004, Pharmaceutical Research.

[32]  A. Dokoumetzidis,et al.  Modeling of supersaturated dissolution data. , 1999, International journal of pharmaceutics.

[33]  J. Siepmann,et al.  Hydrophilic Matrices for Controlled Drug Delivery: An Improved Mathematical Model to Predict the Resulting Drug Release Kinetics (the “sequential Layer” Model) , 2004, Pharmaceutical Research.

[34]  J. Fox,et al.  THEORETICAL MODEL STUDIES OF INTESTINAL DRUG ABSORPTION V. NON-STEADY-STATE FLUID FLOW AND ABSORPTION , 1980 .

[35]  Shlomo Havlin,et al.  On controlled diffusion‐limited drug release from a leaky matrix , 1985 .

[36]  Panos Macheras,et al.  A Population Growth Model of Dissolution , 1997, Pharmaceutical Research.

[37]  P. Macheras,et al.  Determination of fractal reaction dimension in dissolution studies , 1995 .